New article: Strengthening Healthcare Systems Against Substandard Medicines 🏥

In a new article published in Uppsala Reports, BESAFE's Saifuddin Ahmed and others discuss the current state of pharmacovigilance systems globally, highlighting weaknesses, opportunities and potential solutions.

💊 Fake medicines endanger lives.

⏳ It’s time for collective action.

Join us at #BESAFE2025 for expert panels, cross-sector dialogue & action-driven collaboration.

#MedicineSafety #PatientSafety #Conference2025

@johnshopkinssph.bsky.social @hopkinspress.bsky.social

📖New publication: Substandard and falsified medicines (SFMs) are rapidly evolving—but are strategies and solutions keeping up?

Our new scoping review makes the case for more comprehensive solutions to SFMs that go beyond surveillance and regulation.

Read here: www.tandfonline.com/doi/full/10....

🌍 𝑱𝒐𝒊𝒏 𝒖𝒔 𝒇𝒐𝒓 𝒕𝒉𝒆 𝟑𝐫𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐁𝐄𝐒𝐀𝐅𝐄 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 — 𝐎𝐜𝐭 𝟐𝟐–𝟐𝟑, 𝐖𝐚𝐬𝐡𝐢𝐧𝐠𝐭𝐨𝐧, 𝐃𝐂

Global leaders will tackle the urgent threat of falsified & substandard medicines.💊

⏳ Seats are limited — secure yours today:https://besafe2025.dryfta.com/attendee-registration

#PublicHealth #SafeMedicines #GlobalHealth

⚠️ Substandard & falsified (SF) medicines are flooding the digital market.

🎙️Dr. Henry Michtalik explains how you, whether a provider or patient, can identify and report suspicious or counterfeit medical products.

📢 Spread the word. Protect lives.
#DrugSafety #PublicHealth #BESAFE #OnlinePharmacy

🗞️In the news: Saifuddin Ahmed, Principal Investigator at BESAFE, is quoted in a new article published in
@deutschewelle.bsky.social, speaking on the rising global prevalence of substandard and falsified medicines and the need for targeted interventions.